Zenas BioPharma, Inc. (ZBIO) Operating margin 2023–2025
Zenas BioPharma, Inc. (ZBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-3830.6%FY2025 · since FY2023: -74.3% → -3830.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3830.6% | -552.8 pp |
| FY2024 | -3277.8% | -3203.5 pp |
| FY2023 | -74.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating cash flowZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →